Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's Covid-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. - Reuters
NEW DELHI, Feb 22 (Reuters): Indian pharmaceutical companies Bharat Biotech and Biological E. Ltd announced that they could quickly rework their Covid-19 vaccine products to fight new variants once their genetic sequence is known.
In recent months, India has confirmed the presence of the variants first identified in Brazil, Britain and South Africa, which are believed to explain an upsurge in cases in the Indian states of Maharashtra and Kerala.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
